Prevalence and Risk Factors for Missed Short-term Follow-up After Primary Total Shoulder Arthroplasty.


Journal

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
ISSN: 2474-7661
Titre abrégé: J Am Acad Orthop Surg Glob Res Rev
Pays: United States
ID NLM: 101724868

Informations de publication

Date de publication:
01 10 2023
Historique:
received: 22 08 2023
accepted: 03 09 2023
medline: 23 10 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: epublish

Résumé

The importance of consistent postoperative follow-up has been established for collecting patient-reported outcomes and surveilling for potential complications. Despite this, the prevalence of and risk factors for missed short-term follow-up after elective shoulder arthroplasty remain limited. A retrospective review of consecutive primary anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty cases with a minimum of 12-month follow-up performed by a single, fellowship-trained shoulder surgeon was undertaken from January 2015 to December 2021. Demographic patient and surgical data, including age, sex, marital status, self-identified race, body mass index, American Society of Anesthesiologists score, age-adjusted Charlson Comorbidity Index, prior ipsilateral shoulder surgery and/or contralateral arthroplasty, distance from home to clinic, smoking status, and hospital length of stay, were collected. The follow-up at 1 week, 6 weeks, 6 months, 12 months, and 24 months and beyond was determined. Patient-related and surgical predictors for missing the 12-month and 24-month follow-up were identified. There were 295 cases included (168 aTSA and 127 reverse total shoulder arthroplasty), of whom 199 (67%) were women. Of the total cases, 261 (86%) were eligible for 24-month follow-up. Patients undergoing aTSA, those of younger age, those of male sex, and those who missed their 6-week and 6-month follow-up were significantly more likely to miss the 12-month follow-up visit. Following multivariable analysis, a missed 6-month follow-up (OR 10.10, 95% CI 5.32 to 19.16, P < 0.001) was associated with 12-month visit nonattendance, and increasing age (per year) (OR 0.96, 95% CI 0.93 to 0.99, P = 0.011) was associated with improved 12-month follow-up. Not having a surgical complication within 6 months postoperatively, not undergoing ipsilateral revision arthroplasty, and missing the 1-week and 12-month follow-up were significantly associated with missing the 24-month follow-up. After multivariable analysis, missing the 1-week (OR 3.07, 95% CI 1.12 to 8.41, P = 0.029) and 12-month (OR 3.84, 95% CI 2.11 to 6.99, P < 0.001) follow-ups was associated with missing the 24-month visit, whereas having a postoperative complication was associated with increased attendance at 24 months (OR 0.38, 95% CI 0.14 to 0.99, P = 0.047). Strategies for preventing missed short-term follow-up should be focused on ensuring that patients undergoing TSA attend the 6-month and 12-month visit, particularly among younger patients and those with an uneventful postoperative course.

Identifiants

pubmed: 37861416
doi: 10.5435/JAAOSGlobal-D-23-00163
pii: 01979360-202310000-00007
pmc: PMC10584280
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons.

Références

J Bone Joint Surg Am. 2008 Sep;90(9):1848-54
pubmed: 18762643
Orthopedics. 2023 Mar-Apr;46(2):93-97
pubmed: 36476176
J Am Acad Orthop Surg Glob Res Rev. 2022 Jul 6;6(7):
pubmed: 35797623
Can J Surg. 2002 Jun;45(3):191-5
pubmed: 12067171
J Am Acad Orthop Surg Glob Res Rev. 2022 Apr 5;6(4):
pubmed: 35389914
J Hand Surg Am. 2012 Jan;37(1):42-6
pubmed: 22015075
J Bone Joint Surg Am. 2021 Mar 17;103(6):469-476
pubmed: 33369977
J Bone Joint Surg Br. 1997 Mar;79(2):254-7
pubmed: 9119852
J Bone Joint Surg Am. 2017 Jul 5;99(13):1086-1092
pubmed: 28678121
Arch Bone Jt Surg. 2014 Sep;2(3):192-8
pubmed: 25386581
Int J Comput Assist Radiol Surg. 2023 Mar;18(3):595-602
pubmed: 36422767
Am J Sports Med. 2019 Nov;47(13):3173-3180
pubmed: 31589465
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
Int Orthop. 2016 Nov;40(11):2213-2219
pubmed: 27142421
Int J Surg. 2009 Feb;7(1):62-5
pubmed: 19095510
Bone Joint J. 2020 Jul;102-B(7_Supple_B):85-89
pubmed: 32600196
J Bone Joint Surg Br. 2012 Apr;94(4):493-6
pubmed: 22434465
Hand (N Y). 2021 Jan;16(1):104-109
pubmed: 30947548
Clin Orthop Surg. 2022 Mar;14(1):112-118
pubmed: 35251548
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
J Orthop Trauma. 2015 Nov;29(11):510-5
pubmed: 25866940
Knee Surg Sports Traumatol Arthrosc. 2017 Aug;25(8):2481-2487
pubmed: 26724828

Auteurs

Te-Feng Chou (TF)

From the Department of Orthopaedic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (Dr. Chou, Mr. Stallone, and Dr. Gruson); Albert Einstein College of Medicine, Bronx, NY (Ms. Foley and Mr. Rothchild); Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (Dr. Lo).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH